These findings agree with a previous study in 555 unselected cancer patients (including 23 patients with brain cancer) reporting that elevated NT-proBNP concentration was associated with shorter survival independent of patient age, tumor stage and entity, cardiac status, glomerular filtration rate and troponin T concentration10. This evidence concerns the gene NPPB and cancer.